美拉基因治疗 MGTX
$9.00 +$0.49 (+5.76%)
休市 · Nov 6, 8:10 pm ET · 最新盘后价 $9.00 0.00%
开盘$8.44
昨收$8.51
当日区间$8.44 – $9.12
成交量703.3K
市值$864.39M
市盈率（TTM）10.3
股息率–
股权结构与仓位
谁在持有、谁在做空，以及大资金的流向
机构持股比例84.1%-1.89 个百分点，较上季度
持仓机构数198+6 ，较上季度
内部人近期交易28次买入 / 21次卖出净买入
空头持仓比例6.70% 占流通股回补天数 6.5 · 截至 15 Oct 2026
卖空成交量占比29.3%近5日成交量平均占比
卖空成交量占当日成交量比例
大单净流入，近20个交易日
大单买入减卖出的净额（美元）。该窗口期内：−$981.1K（9个净流入日，11个净流出日）。
按单量净流入，近20个交易日
超大单/大单近似机构级别交易；中单/小单近似散户级别交易。各档买入减卖出净额，按窗口期累计。
已披露的前五大股东合计持有45.3%的流通股。
最大股东
按投资者类型
过去6次双周报告中（31 Jul 2026至15 Oct 2026），空头持仓占流通股比例已从4.21%升至6.70%。
近期机构持仓变动
| 股东 | 类型 | 期间 | 持股变动 | 新持股比例 |
|---|---|---|---|---|
| Nuveen Asset Management LLC | Insurance Company | 2026/Q3 | +755,879 | 0.8% |
| Rubric Capital Management LP | Hedge Fund | 2026/Q3 | +2,100,000 | 9.5% |
| BlackRock | Mutual Fund | 2026/Q3 | +1,589,030 | 5.0% |
| Opaleye Management Inc. | Hedge Fund | 2026/Q3 | +1,426,741 | 3.7% |
| Woodline Partners LP | Hedge Fund | 2026/Q3 | +1,199,812 | 1.6% |
| Jacobs Levy Equity Management Inc | Mutual Fund | 2026/Q3 | +1,001,433 | 1.1% |
| Heights Capital Management, Inc. | VC/PE Fund | 2026/Q3 | +850,000 | 0.9% |
| State Street Global Advisors | Mutual Fund | 2026/Q3 | +639,844 | 1.5% |
| Long Focus Capital Management LLC | Hedge Fund | 2026/Q3 | +555,555 | 1.1% |
| Citadel Advisors LLC | Hedge Fund | 2026/Q3 | +534,494 | 0.7% |
| Teachers Insurance and Annuity Association-College Retirement Equities Fund | Mutual Fund | 2026/Q3 | +505,858 | 0.7% |
| Janus Henderson Group plc | Mutual Fund | 2026/Q3 | +475,757 | 0.5% |
| Perceptive Advisors LLC | VC/PE Fund | 2026/Q3 | +460,555 | 11.2% |
| PFM Health Sciences, LP | Hedge Fund | 2026/Q3 | +455,286 | 0.5% |
| D. E. Shaw & Co., L.P. | Hedge Fund | 2026/Q3 | +427,621 | 0.9% |
按报告期列出的机构买卖动态，变动幅度从大到小排列。
内部人交易
| 日期 | 内部人 | 职位 | 交易类型 | 股数 | 价格 | 交易后持股 |
|---|---|---|---|---|---|---|
| 19 Oct 2026 | Richard Giroux | Chief Financial Officer | Automatic Disposition | -56,000 | $9.95 | 942,682 |
| 5 Oct 2026 | Stuart Naylor | Chief Scientific Officer of Ophthalmology | Automatic Disposition | -27,659 | $10.64 | 613,187 |
| 5 Oct 2026 | Stuart Naylor | Chief Development Officer | Intent to Sell (Form 144) | -27,659 | $10.64 | – |
| 22 Sep 2026 | Alan Sebulsky | Director | Other Derivative Acquisition | +100,000 | – | 100,000 |
| 22 Sep 2026 | Apothecary Capital LLC | Initial Statement of Beneficial | +0 | – | 34,500 | |
| 17 Aug 2026 | Alexandria Forbes | Chief Executive Officer | Automatic Disposition | -62,000 | $13.86 | 1,325,695 |
| 20 Jul 2026 | Richard Giroux | Chief Financial Officer | Automatic Disposition | -56,000 | $12.51 | 998,682 |
| 6 Jul 2026 | Stuart Naylor | Chief Scientific Officer of Ophthalmology | Automatic Disposition | -27,659 | $14.90 | 640,846 |
| 24 Jun 2026 | Alexandria Forbes | Chief Executive Officer | Other Derivative Acquisition | +980,000 | – | 980,000 |
| 24 Jun 2026 | Richard Giroux | Chief Financial Officer | Other Derivative Acquisition | +980,000 | – | 980,000 |
| 24 Jun 2026 | Stuart Naylor | Chief Scientific Officer of Ophthalmology | Other Derivative Acquisition | +70,000 | – | 70,000 |
| 24 Jun 2026 | Robert Zeldin | Chief Medical Officer | Other Derivative Acquisition | +100,000 | – | 100,000 |
| 24 Jun 2026 | Robert Wollin | General Counsel | Other Derivative Acquisition | +100,000 | – | 100,000 |
| 10 Jun 2026 | Jiuyun Yu | Independent Director | Other Derivative Acquisition | +60,000 | – | 60,000 |
| 10 Jun 2026 | Thomas Shenk | Independent Director & Member of Scientific Advisory Board | Other Derivative Acquisition | +69,662 | – | 69,662 |
| 10 Jun 2026 | Keith Harris | Independent Chairperson | Other Derivative Acquisition | +106,441 | – | 106,441 |
| 10 Jun 2026 | Perceptive Advisors LLC | Other Derivative Acquisition | +60,000 | – | 60,000 | |
| 10 Jun 2026 | Nicole Seligman | Independent Director | Other Derivative Acquisition | +60,000 | – | 60,000 |
| 10 Jun 2026 | Neil Mendoza | Independent Director | Other Derivative Acquisition | +66,641 | – | 66,641 |
| 10 Jun 2026 | Ellen Hukkelhoven | Director | Other Derivative Acquisition | +60,000 | – | 60,000 |
数据来自Form 4/Form 144申报文件。负数为减持（出售、赠予或代扣税款股份），正数为增持。
空头持仓（按报告期）
| 报告日期 | 空头股数 | 占流通股比例 | 回补天数 |
|---|---|---|---|
| 15 Oct 2026 | 6,438,544 | 6.7% | 6.5 |
| 30 Sep 2026 | 5,996,760 | 6.2% | 5.0 |
| 15 Sep 2026 | 4,011,818 | 4.2% | 6.1 |
| 31 Aug 2026 | 3,723,321 | 3.9% | 4.7 |
| 14 Aug 2026 | 3,738,795 | 3.9% | 8.1 |
| 31 Jul 2026 | 3,897,920 | 4.2% | 8.3 |
暂无评论——快来第一个聊聊 MGTX。
登录后参与讨论。